Both in Pharmaceuticals
Xenetic Biosciences vs Skye Bioscience
Over the past year XBIO returned −29.5% and SKYE returned −90.0%; their daily moves had a correlation of 0.07.
XBIO −29.5% SKYE −90.0%Growth of $1, one year, split-adjusted
| Metric | XBIO | SKYE |
|---|---|---|
| Price | $2.01 | $1.14 |
| Market cap | $4.7M | $5.0M |
| Today | −3.37% | −6.56% |
| 1 month | −5.2% | −29.6% |
| 6 months | −36.6% | −83.3% |
| Year to date | −7.4% | −81.0% |
| 1 year | −35.6% | −90.5% |
| Revenue growth (YoY) | +12.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −140.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.2× | — |
| Net cash | $6.5M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 158.5% | 616.5% |
| Short % of float | 0.5% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).